Health

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-PD-1/HER2 Bispecific Antibody in China

SUZHOU, China, Nov. 27, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today ...

2019-11-27 07:50 3587

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020

HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2019-11-27 05:16 11268

New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...

2019-11-27 02:31 1703

Philips Commended by Frost & Sullivan for Advancing Access to Affordable, High-quality Care through Its Incisive CT Platform

The platform empowers healthcare providers and organizations to deliver on the value-based care promise LONDON, Nov. 26, 2019 /PRNewswire/ -- Based on its recent analysis of the global computed tomography (CT) market, Frost & Sullivan recognizesRoyal Philips (Philips) with the 2019 Global Custom...

2019-11-26 22:00 1199

Japan and Singapore Grant CRISPR Patents to Merck

- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...

2019-11-26 21:00 2158

Manulife launches first-in-market, fully digitized cashless service for day surgeries

HONG KONG, Nov. 26, 2019 /PRNewswire/ -- Manulife Hong Kong today launched Cashless Day Surgery eService, the market's first all-digital cashless service which enables customers to obtain speedy claims pre-approval for colonoscopy and gastroscopy (OGD) day surgery simply by entering their Hong Ko...

2019-11-26 18:31 3698

Ping An Good Doctor Awarded "Listed Enterprise of the Year 2019" by Bloomberg Businessweek/Chinese Edition

SHANGHAI, Nov. 26, 2019 /PRNewswire/ -- Bloomberg Businessweek/Chinese Edition, a renowned Asian financial magazine, announced the winners of the "Listed Enterprises of the Year 2019". The world's leading online healthcare ecosystem platform,Ping An Healthcare and Technology Company Limited ("Pin...

2019-11-26 18:04 4908

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 2476

Program of Building of High-Quality and Efficient Health Service System and Empirical Study in the Context of Aging Kicked off in Beijing

BEIJING, Nov. 25, 2019 /PRNewswire/ -- The MOU signing ceremony and launch seminar forProgram of Building of High-Quality and Efficient Health Service System and Empirical Study in the Context of Aging took place in Beijing today. Government officials and Amgen executives who were present include...

2019-11-25 22:53 1913

Blockchain in Healthcare Will Live Up to the Hype Versus Reality for Stakeholders

SANTA CLARA, California, Nov. 25, 2019 /PRNewswire/ -- With the healthcare industry increasingly going digital, blockchain technology provides the much-needed trust, security, and auditability for healthcare data on its intelligence journey, which allows blockchain to complement healthcare artifi...

2019-11-25 22:10 1559

Xinhua Silk Road: Er-Kang highly recognized for "going global" achievements in Cambodia

PHNOM PENH, Cambodia, Nov. 25, 2019 /PRNewswire/ -- Hunan Er-Kang (Cambodia) Investment Co., Ltd., an overseas arm ofChina's Hunan Er-Kang Pharmaceutical Co., Ltd. (300267.SZ), has recently received a delegation of Communist Party led by Du Jiahao, Secretary of the CPC Hunan Provincial Committee,...

2019-11-25 18:16 1655

USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November

TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...

2019-11-25 15:58 3788

ActLight: Ultra Small, Very Low Power Consumption Heart Rate Monitoring Sensor for Hearables? You Need the ActLight Dynamic Photodiode

LAUSANNE, Switzerland, Nov. 25, 2019 /PRNewswire/ -- Long battery life, precision of measurements and very small size are the key requirements for vital signs monitoring sensors in hearable devices. The Dynamic PhotoDiod...

2019-11-25 08:19 2183

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

SINGAPORE, Nov. 25, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-25 08:15 2175

Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference

SYDNEY, Nov. 25, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share with investors interim data from its ongoing phase II study of GDC-0084 in glioblastoma, the most common and most aggressive form of...

2019-11-25 07:00 2127

CPC Indonesia Design Week Concludes with Local Endorsement

MAKASSAR, Indonesia, Nov. 23, 2019 /PRNewswire/ -- The International Water, Sanitation and Hygiene Foundation's (IWSH) Community Plumbing Challenge (CPC) program has completed its latest installment, a Design Week project in the coastal village of Kampung Nelayan Untia. An intensive four-day ass...

2019-11-23 04:01 1979

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 5547

Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China

BEIJING, Nov. 22, 2019 /PRNewswire/ -- China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO") has successfully completed patient enrollment of the Phase III study of Adapalene-Clindamycin Combin...

2019-11-22 23:50 3476

Guardant Health AMEA wins this year's Growth Excellence Leadership Award by Frost & Sullivan

SINGAPORE, Nov. 22, 2019 /PRNewswire/ -- Guardant Health AMEA has won Frost & Sullivan's Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. "We are delighted to receive this prestigious award from Frost & Sullivan. T...

2019-11-22 15:37 1684

Analytical Wizards secures Series A funding from Sopris Capital

EDISON, New Jersey, Nov. 21, 2019 /PRNewswire/ -- Analytical Wizards, a New Jersey-based global healthcare analytics firm, has announced that it has secured Series A funding from Sopris Capital. Founded in 2015 Analytical Wizards leverages the power of AI/ML, technology, and domain expertis...

2019-11-22 02:11 2263